Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.

Author: DhanjiAl-Rehan, HajekPeter, McRobbieHayden J, MyersKatie E, StapletonJohn

Paper Details 
Original Abstract of the Article :
The use of varenicline tartrate alleviates postquit withdrawal discomfort, but it also seems to reduce the "reward" associated with smoking. The current treatment schedule, which commences 1 week before quitting, relies primarily on the first mechanism. We set out to determine whether increasing the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1001/archinternmed.2011.138

データ提供:米国国立医学図書館(NLM)

Varenicline: A Stepping Stone to Quitting Smoking

Smoking, a habit that can feel like a desert mirage, tempting yet elusive, is a major health concern. Varenicline, a medication used to help people quit smoking, works by reducing withdrawal symptoms and decreasing the pleasure associated with smoking. This study explores whether extending the pre-quit medication period with varenicline could make quitting easier.

The study, conducted by researchers, investigated the effects of using varenicline for four weeks before quitting smoking, compared to the traditional one-week pre-quit period. They found that an extended pre-quit period significantly reduced ad lib smoking and increased smoking cessation rates. This research, like a skilled desert navigator guiding a caravan to a hidden oasis, suggests that a more strategic approach to using varenicline could lead to greater success in quitting smoking.

Extending Varenicline Use: A Path to Easier Quitting

The study's findings suggest that extending the pre-quit varenicline period can be beneficial for smokers, potentially making the quitting process less challenging. This research, like a desert explorer discovering a new route to a distant oasis, could lead to more effective smoking cessation strategies.

Breaking the Habit: A Journey Toward a Smoke-Free Life

This research highlights the potential of extended varenicline use to facilitate smoking cessation, offering a path toward a healthier life. By understanding the impact of this medication on quitting success, we can provide smokers with more effective tools to break their habit and achieve a smoke-free future.

Dr.Camel's Conclusion

This study suggests that extending the pre-quit varenicline period can be an effective strategy for smokers, offering a smoother path to quitting. Like a caravan carefully navigating a challenging desert, individuals on this journey need the right tools and support to make a successful transition to a smoke-free life. This research provides valuable insights into the potential of varenicline to help smokers break free from their habit and embark on a healthier future.

Date :
  1. Date Completed 2011-06-20
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

21518946

DOI: Digital Object Identifier

10.1001/archinternmed.2011.138

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.